Directed Differentation of Human Embryonic Stem Cells in Combination of Biomaterials by Huihui Wang et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Directed Differentation of Human Embryonic 
Stem Cells in Combination of Biomaterials 
Huihui Wang, Xiaojing Xu, Rong Ye and Huanxiang Zhang 
Department of Cell Biology, Medical College of Soochow University, Suzhou 215123,  
China 
1. Introduction 
Human embryonic stem cells (hESC) are derived from the inner cell mass of 
preimplantation embryos and defined by their extensive self-renewal capacity and their 
potential to differentiate into any cell types of three germ layers (ectoderm, mesoderm and 
endoderm). Since the first hESC line was established in the year of 1998, much progress has 
been made on studies of hESC culture, cell line establishment, and directed differentiation.  
2. Culture system of hESC 
Culturing hESC in vitro requires not only keeping their multiplication and undifferentiated 
diploid condition but also maintaining their potential to differentiate into three germ layers. 
hESC lines are traditionally derived and maintained on mouse embryonic fibroblasts (MEF); 
even now using MEF as feeder is one widespread way that scientists adopt for hESC 
cultures. Because of the xenogeneic property of MEF and rapid senescence, people began to 
search for various kinds of human fibroblasts as feeders and the use of them has been 
suggested as a plausible alternative. At present, there have developed many kinds of human 
cell feeders and attempted feeder-free (and serum-free) culture system, non-conditioned 
medium culture system.  
2.1 Feeder-containing culture system  
As one of the earliest used feeders for hESC, MEF promotes hESC proliferation by secreting 
mitogenic factors like fibroblast growth factor (FGF) and inhibit hESC differentiation by 
secreting differentiation inhibiting factors like leukaemia inhibitory factor (LIF). However, 
not only MEF enter senescence rapidly, but also need prepare primary MEF cells 
uninterruptedly. Moreover the use of MEF and other components of animal origin in the 
culture media for hESC substantially elevates the risk of contaminating these cell lines with 
infectious agents of animal origin, thereby severely limiting their potential for clinical 
application[1]. As the therapeutic potential of hESC lies in the transplantation of 
differentiated cell types for various degenerative diseases, it is important to eliminate 
potential xenogeneic contamination[2]. Otherwise, hESC in prolonged culture in vitro may 
cause higher karyotype instability and uncontrollable spontaneous differentiation 
phenomenon, which also confine manipulation in clinical application[3]. Accordingly, many 
research groups attempt to use various kinds of human-source cells as feeders, such as 
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human embryo fibroblast[4], adult fetal muscle fibroblast, adult skin and adult fallopian 
tube, human marrow stromal cells (hMSC)[5], human foreskin fibroblast (hFF)[6], human 
placenta-derived feeder (HPC)[7], human amniotic epithelial (HAE)[8], and post natal human 
fibroblast.  
The number of colonies, number of cells produced, and cell survival rates, all of these 
indexes are significantly higher on MEF than on human feeder cells (P < 0.01) and the 
number of AP-positive colonies and cell quantity are also significantly higher on hMSC than 
on hFF (P < 0.01). It implies that hMSC is superior to hFF in supporting the proliferation of 
hESC[9]. SNUhES3 (hESC line) cultured on MEF for 50 passages display three chromosomal 
abnormalities: t(3:5) in the 10th, trisomy 12 in the 20th, and complex of t(3:5) and trisomy 12 
in the 30th passage. In the HPC group, only one chromosomal abnormality is noted at the 
30th passage: t(3:5)[7]. 
In another study, people derivatized FGF2 expressing germ layer derived fibroblast cells 
(GLDF) from hESC lines[2]. These feeder cells with fibroblast cells-like properties 
maintained the properties of hESC in prolonged culture over 30 passages. Furthermore, 
these GLDF cells could secrete FGF2 to maintain pluripotency of hESC cultures even in 
the absence of supplemental FGF2. Otherwise human embryonic lung fibroblasts 
(hELF)[10] overexpress LIF that result in the higher expressing of hESC multipotency genes 
Oct4 and Nanog. 
Choosing human-derived cells as feeders solves the puzzle of biological safety in some 
degree, but need to prepare and identify the feeder uninterruptedly. Moreover, the growth 
cycle is finite, the manipulation is elaborate, all of this limite hESC large amplification and 
stable passage, bring disadvantages to large-scale culture of hESC[11]. To overcome this 
constraint, there has developed feeder-free culture system. It may not only offer chance for 
hESC large-scale culture but also accelerate the step of clinical application. 
2.2 Feeder-free culture system 
In order to simplify the culture of hESC, several research groups have engaged to establish 
the feeder-free culture system. Unlike feeder-based cultures, which require the simultaneous 
growth of feeder and stem cells, resulting in mixed cell populations, stem cells grown on 
feeder-free systems are easily separated from the surface, presenting a pure population of 
cells for downstream applications. The conditioned medium is prepared by adding 
proliferation promoting factors and differentiation inhibiting factors, or cells that secrete the 
above factors are used. Two main strategies are adopted: (1) using conditioned medium 
(CM) and culture dishes coated with extracellular matrix as matrigel, laminin or fibronectin; 
(2) feeder-free and serum-free culture system, in which hESC are cultured in special 
medium containing serum replacement (SR) and various kinds of growth factors promoting 
hESC self-renewal. 
It has been successful to culture hESC using feeder-free system with matrigel or laminin, 
but MEF conditioned medium is required which may propagate infectious agents of 
animal origin to hESC[12]. Besides, matrigel is a mixture derived from murine tumors, 
containing many extracellular matrix and various kinds of growth factors. For this reason, 
the ideal feeder-free cultures should deploy xeno-free extracellular matrix and 
conditioned medium. 
A novel feeder layer-free culture system for hESC, has been presented. The defined culture 
system is based on serum replacement, a combination of growth factors including 
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transforming growth factor ┚1 (TGF┚1), LIF, bFGF and fibronectin matrix[13]. BMP-11/GDF-
11 and Myostatin/GDF-8 are both members of the TGF-┚ superfamily that can activate 
SMAD2/3phosphorylation via the type I receptors ALK4, ALK5, or ALK7, ultimately 
maintain hESC undifferentiated, maintain POU5f1, NANOG, TRA-1-60, and SSEA4 
normally expression[14]. BMP4 synergizing with LIF can maintain mouse ESC self-renewal, 
while BMPs alone induce hESC differentiation. hESC cultured in unconditioned medium 
(UM) are subject to high levels of BMP signaling activity. The BMP antagonist noggin 
synergizes with bFGF to repress BMP signaling and sustain undifferentiated proliferation of 
hESC in the absence of fibroblasts[15].  
Genetic manipulation of hESC is important for both present research and future commercial 
applications. Under the feeder-free and serum-free conditions, plasmid transfection, virus 
infection, and siRNA transfection are highly effective. Stable genetically modified hESC 
lines can be generated with these genetic manipulations without loss of pluripotency or 
differentiation potential. The majority of lines generated in this system display a normal 
karyotype[16]. Immunofluorescence microscopy and quantitative PCR analyses of hESC 
under feeder-free conditions have illustrated with new results on cellular localization of 
transcriptional factors and components of the Hedgehog, Wnt, and PDGF signaling 
pathways to primary cilia in stem cell maintenance and differentiation[17].  
3. Directed differentiation of hESC 
Upon differentiation, hESC can give rise to a variety of cell types, including nerve cells, 
cardiac muscle cells, endothelial cells, hematopoietic cells, and insulin-producing beta cells, 
highlighting the importance of these cells in studying the developmental mechanisms and 
the potential in transplant therapy.  
3.1 Neural cells 
Studies indicated that neuroectodermal precursors in neural rosettes could be induced by 
replating EBs into the DMEM/F12 medium containing insulin, transferrin (TFN), corporin, 
putrescine, liquemine, FGF2. Immunostaining of neuroectodermal cells in rosettes for early 
neural markers Sox1 and nestin, and the neuronal marker TuJ1, showed that the radially 
organized columnar neuroepithelial cells coexpressed Sox1 and nestin[18]. All these hESC-
derived neural progenitor cells could differentiate into neurons, astrocytes and 
oligodendrocytes. 
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by progressive and 
selective loss of dopaminergic (DA) neurons in the midbrain substantia nigra[19]. The 
prevailing pharmacological strategy has side effects over time, therefore, much attention has 
been focused on the transplantation of DA-synthesizing cells. Studies showed that after 
differentiation of passage 2 cells, 30–50% of the total cells derived from hESC were Tuj1-
positive neurons, among the Tuj1-positive neuronal population 64–79% of the cells 
expressed TH[20]. 
For the purpose of applying the hESC to PD, many researchers have tried to develop 
protocols increasing the purity of DA neurons. Myung Soo Cho, etc [21] introduce a method 
that hESC give rise to functional tyrosine hydroxylase-positive (TH+) neurons up to nearly 
86% of the total hESC-derived neurons. The most unique feature of this method is the 
generation of homogeneous spherical neural masses (SNMs) from the hESC-derived neural 
precursors, and it only takes two weeks to induce of DA neurons from SNMs.  
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hESC-derived DA nerons and neural progenitors raise Ca2+ from intra- and extracellular 
compartments in response to depolarization, glutamate, ATP and dopamine D2 receptor 
activation, while cAMP is elevated in response to forskolin and 3-isobutyl-
methylxanthine[22]. Analysis of hESC and hESC-derived neural stem cell nuclear extracts 
revealed an increased expression of Reptin52 in neurosphere nuclei[23] that serves a pivotal 
regulatory role in nuclear activities such as transcription regulation and histone 
modification. 
The development of stem cell-based neural repair strategies requires detailed knowledge on 
the interaction of migrating donor cells with the host brain environment. hESC-derived glial 
precursors (ESGPs) transduced with a retrovirus encoding the polysialyltransferase STX 
exhibit overexpression of polysialic acid(PSA) which is a carbohydrate polymer attached to 
the neural cell adhesion molecule (NCAM) [24]. Chemotaxis assays show that overexpression 
of PSA results in an enhanced chemotactic migration of these cells toward gradients of a 
variety of chemoattractants, including FGF2, platelet-derived growth factor (PDGF), and 
brain-derived neurotrophic factor (BDNF), and this effect is mediated via the 
phosphatidylinositol 3’-kinase (PI3K) pathway. 
3.2 Hematopoietic stem cells 
The most common human cell-based therapy applied today is hematopoietic stem cell 
(HSC) transplantation[25]. Human bone marrow, mobilized peripheral blood, and umbilical 
cord blood are considered as the major sources of transplantable HSCs, but both 
compatibility between donor and recipient and required quantity limit their clinical 
application. In contrast, hESC have been shown to differentiate into the hematopoietic cell 
fate, providing an alternative source of transplantable blood cells. hESC-derived 
hematopoietic stem cells which emerge from a subset of embryonic endothelium expressing 
PECAM-1, Flk-1, and VE-Cadherin, but lacking CD45 (CD45negPFV) show similar 
clonogenic capacity and primitive phenotype to somatic sources of hematopoietic 
progenitors and possess limited in vivo repopulating capacity in immunodeficient mice. A 
subset of hESC-derived CD45+ hematopoietic cells coexpress CD34 and show progenitor 
function in colony-forming units assays. However, compared to HSC from fetal blood (FB) 
or cord blood, these hESC-HSC display distinct functional properties, including poor 
repopulation ability, impaired differentiation and lack of homing[26]. Only 2.4% of 
differentially expressed transcripts were common for FB–HSCs and candidate hESC-
HSCs[26], suggesting a completely different molecular signature for HSCs isolated from two 
different in utero ontogeny stages. Several key hematopoietic transcription factors, such as 
RUNX3, TAL1, VAV1, LMO2, AML-1, and c-mac, apoptosis and cycle regulators, such as 
CDC42, CDC27, CyclinD3 and CDK4, and cell aggregation and homing genes may 
contribute to explain the functional differences between hESC-HSCs and FB-HSCs. 
Importantly, the gene expression profiling study revealed that developmental signaling 
pathways such as Notch, Wnt, BMP, Shh are involved in HSC self-renewal and 
hematopoietic specification.  
Several complementary methods are used to demonstrate canonical Wnt signaling that is 
important for development of hESC-derived cells with both hematopoietic and endothelial 
potential[27]. The development of cells with hematoendothelial potential decreases 
dramatically when treated with dickkopf1 which inhibits Wnt signaling. In addition, 
activation of the canonical Wnt signaling pathway in hESC by coculture with stromal cells 
that express Wnt1, but not use of noncanonical Wnt5-expressing stromal cells, results in an 
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accelerated differentiation and higher percentage of CD34brightCD31+Flk1+cells at earlier 
stages of differentiation. 
3.3 Mesenchymal stromal cells 
Mesenchymal stromal cells (MSCs), originally isolated from adult bone marrow (BM), have 
also been derived from hESC, either through coculturing with the OP9 murine BM stromal 
cell line or directly from ESCs cultured without feeder cells[28,29]. The simultaneous 
generation of CD73+ MSCs along with CD34+ hematopoietic cells from HESC has been 
shown when they are cocultured with OP9 murine stromal cells[28]. hESC–derived MSCs 
show spindle-shaped fibroblast-looking morphology, exhibit similar cell surface marker 
CD29, CD44, CD54, CD73, CD90 and CD105, but negative for CD34, CD45, and the 
endothelial marker CD31, characteristics when compared to BM-derived MSCs, and could 
differentiate into osteocytes, adipocytes, and chondrocytes. 
3.4 Insulin-producing β cells 
Type I diabetes is a disease in which ┚-cells of the pancreas are destroyed by an autoimmune 
mechanism[30]. Use of exogenous insulin to treat diabetes is life-saving; however, it does not 
truly mimic the body’s natural response to blood glucose[31]. Islet cell transplantation is 
currently considered to be an important method of therapy[32]. But the scarcity of islets 
prevents this therapy. The isolation of hESC introduced a new prospect for obtaining a 
sufficient number of ┚ cells for transplantation. Segev et al. present a method for forming 
immature islet-like clusters of insulin-producing cells derived from hESC[33]. Seven-day-old 
EBs were first cultured and plated in insulin-transferrin-selenium-fibronectin medium (ITSF) 
about a week, followed by medium supplemented with N2, B27, and bFGF. At the next stage, 
bFGF was removed and nicotinamide was added, and the total glucose concentration in the 
medium was reduced.  After 4 days of culture, the formation of clusters exhibited higher 
insulin secretion and had longer durability than cells grown as monolayers. Gen-hong Mao[34] 
demonstrates a five-stage protocol with adding exendin-4 instead of nicotinamide and 
generates islet-like cells from human embryonic stem (ES) cells. Immunofluorescence analysis 
revealed that most c-peptide positive cells coexpressed inlusin, PDX-1 (pancreas duodenum 
homeobox-1), glucagon, somatostatin or pancreatic polypeptide. Insulin and other pancreatic 
┚-cell-specific genes were all present in the differentiated cells. 
Following the illumination of hESC differentiation mechanism and successfully culturing 
various kinds of terminal differentiated cells, tissues and organs, it may apply functioning 
cells of hESC-source in replacement therapies. 
4. hESC coupled with biomaterials 
Tissue engineering is the study of the growth of new connective tissues or organs, from cells 
and a collagenous scaffold to produce a fully functional organ for implantation back into the 
donor host. Scaffolding can be used as a cell support device upon which cells are seeded in 
vitro; cells are then encouraged to lay down matrix to produce the foundations of a tissue 
for transplantation. Tissue engineering scaffolds are designed to influence the physical, 
chemical and biological environment surrounding a cell population[35]. Many matrix 
materials that are in application of current research are mainly natural materials, synthetic 
polymer and biodegradable materials, ceramic materials and their complex formed between 
the composite materials. Natural biological materials, compared with synthetic materials, 
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have many advantages, the abundant source, low cost, and with good biocompatibility, and 
that some materials have pore structure of natural systems. Currently, the mainly applied 
materials are collagen (type I collagen in the main), gelatin, chitin, chitosan, natural coral 
and its derivatives. Now the synthetic biodegradable polymer materials that extensively 
used are mainly polylactic acid (PLA), polyglycolic acid (PGA) and various copolymers 
between them. These materials are bulk-degrade by hydrolysis, providing a controllable 
drug release and degradation profile to match tissue in-growth. The main structures of PLA, 
PGA and their copolymers used in tissue engineering applications are in the form of fibrous, 
porous foam and tubular structure.  
4.1 Electrospun fibrous scaffolds 
Electrospun fibrous scaffolds can be prepared with high degree of control over their 
structure creating highly porous meshes of ultrafine fibers that mimic the natural three-
dimensional environment of the in vivo extracellular matrix (ECM), and are amenable to 
various functional modifications targeted towards enhancing stem cell survival and 
proliferation, directing specific stem cell fates, or promoting tissue organization[36]. Evidence 
shows that of electrospun biodegradable polymers as scaffolds not only enhances the 
differentiation of mouse ES cells into neural lineages but also promotes and guides the 
neurite outgrowth[37]. Cultivation of hESC on electrospun fibrous polyurethane scaffolds 
also proved successful and neuronal differentiation was observed via standard 
immunocytochemistry[38]. Scanning electron micrographs confirmed neurite outgrowth and 
connection to adjacent cells, as well as cell attachment to individual fibers of the fibrous 
scaffold. Scaffold architecture has been shown to modify the response of cells and 
subsequent tissue formation, as demonstrated by the generation of mineralization fronts in 
specific regions of scaffolds. Nano to microscale topography has been demonstrated to affect 
cell behavior by modification of cytoskeleton arrangements. 
Although complex structures are formed, the mechanism of adhesion of hESC to the 
surfaces of the scaffolds remains largely unknown. Steven Y. Gao[39] achieved the efficient 
adhesion of pluripotent hESC to 3D PLGA scaffolds. In the 2-D PLGA model, the scaffold 
surfaces were coated with laminin and flow cytometry analysis revealed that almost all of 
the pluripotent single cells expressed the integrin ┙6, with a small percentage also 
expressing ┙3┚1, which facilitates adhesion to laminin. In the 3-D enviroment, the results 
were similar to those gained from the 2-D model, which suggests that the adhesion of 
pluripotent hESCs is mainly affected by the surface properties that they adhere onto rather 
than the geometric properties of the culture system. 
4.2 Porous foam scaffolds 
Porous biodegradable polymer scaffolds can be used to support ES cells because they 
represent a promising system for allowing formation of complex 3D tissues during 
differentiation[40]. The scaffolds which consist of a 50/50 blend of PLGA and PLLA could 
support hESC that remain viable for at least 2 weeks in vivo. Two weeks after 
transplantation of hESC-scaffold constructs into SCID mice, defined epithelial tubular 
structures and neural tube-like rosettes were observed. In addition, when cultured in vitro 
with both NGF and NT-3, enhanced numbers of neural structures and staining of nestin and 
┚III-tubulin were observed with hESC-seeded polymer scaffolds[41]. NGF and RA 
preferentially favor the differentiation toward ectodermal and mesodermal lineages[42]. 
Subcutaneous transplantation of PLGA scaffolds seeded with the hESC-derived islet-like 
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cells or cell transplantation under kidney capsules for further differentiation in vivo could 
improve 6 h fasted blood glucose levels and diabetic phenotypes in streptozotocin-induced 
diabetic SCID mice[34]. More interestingly, blood vessels of host origin can be observed, 
invading the cell–scaffold complexes. This suggests scaffolds can serve as vehicles for islet-
like cell transplantation. 
Other study has certificated that 3D porous alginate scaffolds provide a conductive 
environment for generation of well-vascularized EBs from hESC[43]. EBs can be generated 
directly from hESC suspensions within 3D porous alginate scaffolds. The alginate scaffold 
pores which provide a confining environment enable efficient formation of round, small-
sized EBs with a relatively high degree of cell proliferation and differentiation, and induce 
vasculogenesis in the forming EBs to a greater extent. Recent study demonstrated that 3D 
porous natural polymer scaffold, comprised of chitosan and alginate, could support 
sustained self-renewal of hESCs without the support of feeder cells or conditioned 
medium[44]. 
4.3 Other scaffolds 
Scaffolds can be used as a growth factor/drug delivery device[35]. This strategy involves the 
scaffold being combined with growth factors, so upon implantation cells from the body are 
recruited to the scaffold site and form tissue upon and throughout the matrices. Recently, 
vascular progenitor cells as well as endothelial and smooth muscle cells have been isolated 
from hESC encapsulated in bioactive hydrogel-based scaffolds combined with immobilized 
regulatory factors: a tethered RGD peptide and microencapsulated VEGF165[45]. Others have 
investigated the functions of hESC-derived neural progenitor cells (hESC-NPC) after 
transplanted in collagen scaffolds supplemented with growth factors[46] and reveal that 
implantation of hESC-NPC into the spinal cord with collagen scaffold improved the 
recovery of hindlimb locomotor function and sensory responses in an adult rat model of 
SCI.  
Tzu-I Chao, et al.[47] have reported that 2D thin film scaffolds composed of biocompatible 
polymer grafted carbon nanotubes (CNTs), can selectively differentiate hESC into neurons 
while maintaining excellent cell viability. According to fluorescence image analysis, neuron 
differentiation efficiency of polyacrylic acid grafted CNT thin films is greater than that on 
polyacrylic acid thin films. Other comparison has been done between silk and chitosan 
scaffolds in chondrogenesis of human cell sources[48]. After 4 weeks of cultivation, hESC-
derived MSCs were promising for chondrogenesis, particularly in the silk scaffolds with 
BMP6. The polyurethane acrylate (PUA), fabricated into nanoscale ridge/groove pattern 
arrays with its surface treated in oxygen plasma for 60s Results showed that after alone[49] 
can effectively and rapidly induce the differentiation of hESC into a neuronal lineage 
without the addition of any biochemical or biological agents. 
Future applications of those versatile scaffolds platform to human embryonic and induced 
pluripotent stem cells for functional tissue repair and regeneration will further expand its 
potential for regenerative therapies. 
5. Prospect of HESC 
Expecting to use hESC largely and safely in clinical, there are a lot of works to do. hESC 
differentiation is typically stimulated via generation of EBs and lineage commitment of 
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individual cells depends upon numerous cues throughout the EB environment, including 
EB shape and size. Common EB formation protocols, however, produce a very 
heterogeneous size distribution, perhaps reducing efficiency of directed differentiation[50]. 
Some scholars have developed a 3-D microwell-based method to maintain undifferentiated 
hESC cultures for weeks without passaging using physical and extracellular matrix 
patterning constraints to limit colony growth. Microwell culture also permits formation of 
hESC colonies with a defined size, which can then be used to form monodisperse EBs. When 
cultured in this system, hESC retained pluripotency and self-renewal, and were able to be 
passaged to standard unconstrained culture conditions. 
Successful clinical implementation of tissue engineering products generated from ESCs 
would require a controlled reproducible culture system for the expansion of the cells and 
differentiation into functional tissues. It is a marvelous scenario which involve combination 
of the bioreactor expansion and subsequent differentiation of the ESCs to generate the 
specialized cell types. N. I. zur Nieden[51] showed that suspension bioreactors which can 
be adapted for long term culture could be used in the regulated large-scale expansion of 
highly pluripotent murine ESCs. The ESC cultures remain highly undifferentiated, when 
serially passaged in suspension bioreactors for extended periods. Otherwise different 
growth factors have different effects on cell proliferation and differentiation[52]. BMPs 
have previously been shown to induce hESC differentiation, in apparent contrast to 
mouse embryonic stem (ES) cells, in which BMP4 synergizes with LIF to maintain self-
renewal. The BMP antagonist noggin synergizes with bFGF to repress BMP signaling and 
sustain undifferentiated proliferation of hESC in the absence of fibroblasts or CM. These 
findings suggest a basic difference in the self-renewal mechanism between mouse and 
human ES cells. 
Stem cells and human tissue engineering are two hot spots. Many scholars attempt to 
combine hESC with tissue engineering. Although transplantation of ES cells-derived neural 
progenitor cells has been demonstrated with some success for either spinal cord injury 
repair in small animal model, control of ES cell differentiation into complex, viable, higher 
ordered tissues is still challenging[37]. 
Silk fibroin (SF), the core structural protein of Bombyx mori silkworm silks, has widely been 
studied as biomaterials in tissue engineering and regenerative medicine due to the 
biocompatibility, impressive mechanical property, high yields through sericulture and 
controllability of degradability, as well as the versatility in processing, the availability of 
different morphologies and the ease of sterilization and surface modification of these SF-
based materials. While a number of studies detailed the ability of SF to support the 
attachment and growth of a variety of human cell types and the promising applications of 
SF scaffolds in wound healing and in bone, cartilage, blood vessel, tendon, or ligament 
tissue engineering, there is little information about the interaction of astroglial and neuronal 
cells with SF-based scaffolds.  
Among all the silk materials in different morphologies, of great interest are the electrospun 
nonwoven SF nanofibers or nets that mimic the nanostructured components of the 
extracellular matrix and are supposed to provide more surface area and rougher topography 
for cell attachment. Upon implantation these nanofibrous SF scaffolds might ameliorate the 
conditions at the injury sites via the formation of the oriented network of astroglial and 
neuronal cells by arranging these cells along the nanofibers and guiding axonal outgrowth, 
and finally prevent the formation of physical and molecular barriers to the CNS repair. 
Nonwoven SF nanofibers were studied with a variety of cells, but little information is 
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hitherto available with neurons, astrocytes and their progenitors, the main cell types 
participating in the glial scaring.  
Tussah silk is a type of wild silks, and the chemical structure, molecular conformation and 
physical properties of tussah silk fibroin (TSF) have been extensively studied. In contrast to 
Bombyx mori silkworm silk fibroin (SF), the amino acid composition of TSF is characterized 
by more Ala, Asp and Arg contents, and less Gly, and the presence of tripeptide sequence 
Arg-Gly-Asp (RGD), which is known to promote cell attachment and thus might make TSF 
an even more promising biomaterial for use in biomedical applications and tissue 
engineering. 
In an attempt to develop strategies for fabricating nerve implants, using the regenerated SF, 
TSF, or blends of both at different proportions, that could be applied in vivo as the cell 
substrates to control the arrangement of astroglial cells and guide the axon growth, we 
prepared nonwoven nanofiber scaffolds by electrospinning and analyzed the behavior of 
astrocytes, neurons and neural progenitor cells, isolated from newborn rat cerebral cortex or 
derived from hESC, on these nonwoven fibroin nanofibers. In particular, we focused on the 
migration and spreading, in addition to the attachment, viability and proliferation of these 
cells. Our long-term goal is to identify the optimum conditions in the context of the 
properties of the nanofiber substrates that may allow for the manipulation of astroglial cells 
and ameliorate the nonpermissiveness of the CNS injury sites upon implantation.  
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